X Yao, Y Huang
Index: Life Sci. 66(1) , PL13-9, (2000)
Full Text: HTML
Quaternary ammonium ions are common pharmacological blockers of K+ channels. This study examined the vasorelaxant effect of tetraoctylammonium ions (TOA+) in rat isolated aortic rings. TOA+ caused a concentration-dependent transient relaxation of endothelium-intact tissues. Pretreatment with NG-nitro-L-arginine methyl ester (L-NAME, 3x10(-5) M) or methylene blue (3 x 10(-6) M) or removal of the endothelium abolished the TOA+-induced relaxation. L-arginine (10(-3) M ) partially antagonized the effect of L-NAME. Glibenclamide (3x10(-6) M), charybdotoxin (CTX, 10(-7) M), indomethacin (10(-5) M), or atropine (3x10(-6) M) had no effect. Both TOA+ (10(-5) M)- and acetylcholine (ACh, 10(-5) M)-induced increase in tissue content of cyclic GMP was significantly attenuated by NG-nitro-L-arginine (L-NNA, 10(-4) M) and abolished in endothelium-denuded arteries. These results indicate that TOA+ induced endothelium-dependent relaxation which is likely mediated through nitric oxide but not other endothelium-derived factors. This relaxant action seems unique for TOA+ since other quaternary ammonium ions did not cause nitric oxide-dependent relaxation.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
N,N,N-Tripentyl-1-pentanaminium bromide
CAS:866-97-7 |
C20H44BrN |
KCNE1 reverses the response of the human K+ channel KCNQ1 to...
2000-12-01 [Pflugers Arch. 441(2-3) , 368-78, (2000)] |
Early-phase occurrence of K+ and Cl- efflux in addition to C...
2012-08-01 [Apoptosis 17(8) , 821-31, (2012)] |
Frequency dependence of alternating current electrospray ion...
2011-04-15 [Anal. Chem. 83(8) , 3017-23, (2011)] |
Effect of urea on the ion-association capillary electrophore...
2010-01-01 [Anal. Sci. 26(11) , 1151-6, (2010)] |
Tetrapentylammonium block of chloramine-T and veratridine mo...
2001-04-01 [Br. J. Pharmacol. 132(8) , 1755-60, (2001)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved